Cargando…

The Expanding Therapeutic Utility of Botulinum Neurotoxins

Botulinum neurotoxin (BoNT) is a major therapeutic agent that is licensed in neurological indications, such as dystonia and spasticity. The BoNT family, which is produced in nature by clostridial bacteria, comprises several pharmacologically distinct proteins with distinct properties. In this review...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fonfria, Elena, Maignel, Jacquie, Lezmi, Stephane, Martin, Vincent, Splevins, Andrew, Shubber, Saif, Kalinichev, Mikhail, Foster, Keith, Picaut, Philippe, Krupp, Johannes
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983264/ https://www.ncbi.nlm.nih.gov/pubmed/29783676 http://dx.doi.org/10.3390/toxins10050208

Ejemplares similares

The Isolated Mouse Jejunal Afferent Nerve Assay as a Tool to Assess the Effect of Botulinum Neurotoxins in Visceral Nociception
por: Retailleau, Kevin, et al.
Publicado: (2022)

Botulinum Neurotoxins Serotypes A and B induce paralysis of mouse striated and smooth muscles with different potencies
por: Maignel‐Ludop, Jacquie, et al.
Publicado: (2017)

Engineered botulinum neurotoxin B with improved binding to human receptors has enhanced efficacy in preclinical models
por: Elliott, Mark, et al.
Publicado: (2019)

Evaluation of Recombinant Botulinum Neurotoxin Type A1 Efficacy in Peripheral Inflammatory Pain in Mice
por: Oehler, Beatrice, et al.
Publicado: (2022)

Recombinant botulinum neurotoxin serotype A1 in vivo characterization
por: Périer, Cindy, et al.
Publicado: (2021)

A comparison of biological activity of commercially available purified native botulinum neurotoxin serotypes A1 to F1 in vitro, ex vivo, and in vivo
por: Donald, Sarah, et al.
Publicado: (2018)

Augmentation of VAMP-catalytic activity of botulinum neurotoxin serotype B does not result in increased potency in physiological systems
por: Elliott, Mark, et al.
Publicado: (2017)

AbobotulinumtoxinA (Dysport(®)), OnabotulinumtoxinA (Botox(®)), and IncobotulinumtoxinA (Xeomin(®)) Neurotoxin Content and Potential Implications for Duration of Response in Patients
por: Field, Malgorzata, et al.
Publicado: (2018)

New Modified Recombinant Botulinum Neurotoxin Type F with Enhanced Potency
por: Burgin, David, et al.
Publicado: (2021)

Engineering Botulinum Toxins to Improve and Expand Targeting and SNARE Cleavage Activity
por: Fonfria, Elena, et al.
Publicado: (2018)

Correction: Field, M. et al. AbobotulinumtoxinA (Dysport(®)), OnabotulinumtoxinA (Botox(®)), and IncobotulinumtoxinA (Xeomin(®)) Neurotoxin Content and Potential Implications for Duration of Response in Patients
por: Field, Malgorzata, et al.
Publicado: (2019)

hiPSC-Derived Neurons Provide a Robust and Physiologically Relevant In Vitro Platform to Test Botulinum Neurotoxins
por: Lamotte, Juliette Duchesne De, et al.
Publicado: (2021)

Optimization of the rat digit abduction score (DAS) assay: Evaluation of botulinum neurotoxin activity in the gastrocnemius lateralis, peronei, and extensor digitorum longus
por: Cornet, Sylvie, et al.
Publicado: (2020)

BoNT/A1 Secondary Failure for the Treatment of Neurogenic Detrusor Overactivity: An Ex Vivo Functional Study
por: Maignel, Jacquie, et al.
Publicado: (2022)

The use of the dynamic weight bearing test to assess the effects of acute, intramuscularly administered botulinum neurotoxin type A1 in rats
por: Cornet, Sylvie, et al.
Publicado: (2020)

On Botulinum Neurotoxin Variability
por: Montecucco, Cesare, et al.
Publicado: (2015)

Engineered botulinum neurotoxin B with improved efficacy for targeting human receptors
por: Tao, Liang, et al.
Publicado: (2017)

Why Are Botulinum Neurotoxin-Producing Bacteria So Diverse and Botulinum Neurotoxins So Toxic?
por: Poulain, Bernard, et al.
Publicado: (2019)

Zebrafish Sensitivity to Botulinum Neurotoxins
por: Chatla, Kamalakar, et al.
Publicado: (2016)

Use of Botulinum Neurotoxin in Ophthalmology
por: Başar, Emel, et al.
Publicado: (2016)

Antipruritic Effects of Botulinum Neurotoxins
por: Gazerani, Parisa
Publicado: (2018)

Therapy of Sialorrhea with Botulinum Neurotoxin
por: Jost, Wolfgang H., et al.
Publicado: (2019)

Botulinum neurotoxins: Future innovations
por: Brideau-Andersen, Amy, et al.
Publicado: (2023)

Split luciferase-based assay to detect botulinum neurotoxins using hiPSC-derived motor neurons
por: Cotter, Laurent, et al.
Publicado: (2023)

Conjugative Botulinum Neurotoxin-Encoding Plasmids in Clostridium botulinum
por: Marshall, Kristin M., et al.
Publicado: (2010)

Emerging Opportunities for Serotypes of Botulinum Neurotoxins
por: Peng Chen, Zhongxing, et al.
Publicado: (2012)

Engineering of Botulinum Neurotoxins for Biomedical Applications
por: Webb, Robert P.
Publicado: (2018)

Botulinum neurotoxin formulations: overcoming the confusion
por: Samizadeh, Souphiyeh, et al.
Publicado: (2018)

Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology
por: Pirazzini, Marco, et al.
Publicado: (2017)

Botulinum Neurotoxin for the Treatment of Neuropathic Pain
por: Egeo, Gabriella, et al.
Publicado: (2020)

Tables of Toxicity of Botulinum and Tetanus Neurotoxins
por: Rossetto, Ornella, et al.
Publicado: (2019)

Botulinum Neurotoxin Injections in Childhood Opisthotonus
por: Hull, Mariam, et al.
Publicado: (2021)

Recent Developments in Botulinum Neurotoxins Detection
por: Rasetti-Escargueil, Christine, et al.
Publicado: (2022)

Botulinum Neurotoxins: From Toxin to Medicine
por: Santamato, Andrea
Publicado: (2023)

Engineering an Effective Human SNAP-23 Cleaving Botulinum Neurotoxin A Variant
por: Sikorra, Stefan, et al.
Publicado: (2020)

Onset dynamics of type A botulinum neurotoxin-induced paralysis
por: Lebeda, Frank J., et al.
Publicado: (2008)

Comment on: Botulinum Toxin Type A Overdoses: Analysis of the FDA Adverse Event Reporting System Database
por: Picaut, Philippe
Publicado: (2018)

The Zinc-Dependent Protease Activity of the Botulinum Neurotoxins
por: Lebeda, Frank J., et al.
Publicado: (2010)

Neurologic uses of botulinum neurotoxin type A
por: Ney, John P, et al.
Publicado: (2007)

Tyrosine Phosphorylation of Botulinum Neurotoxin Protease Domains
por: Toth, Stephen, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_m75dfmeg8gah7ganbgltd4otd8